Comparative Serum Proteome Profiling of Canine Benign Prostatic Hyperplasia before and after Castration
5
Issued Date
2023-12-01
Resource Type
eISSN
20762615
Scopus ID
2-s2.0-85180677242
Journal Title
Animals
Volume
13
Issue
24
Rights Holder(s)
SCOPUS
Bibliographic Citation
Animals Vol.13 No.24 (2023)
Suggested Citation
Ploypetch S., Wongbandue G., Roytrakul S., Phaonakrop N., Prapaiwan N. Comparative Serum Proteome Profiling of Canine Benign Prostatic Hyperplasia before and after Castration. Animals Vol.13 No.24 (2023). doi:10.3390/ani13243853 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/95654
Title
Comparative Serum Proteome Profiling of Canine Benign Prostatic Hyperplasia before and after Castration
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
BPH is the most prevalent prostatic condition in aging dogs. Nevertheless, clinical diagnosis and management remain inconsistent. This study employed in-solution digestion coupled with nano-liquid chromatography tandem mass spectrometry to assess serum proteome profiling of dogs with BPH and those dogs after castration. Male dogs were divided into two groups; control and BPH groups. In the BPH group, each dog was evaluated at two time points: Day 0 (BF subgroup) and Day 30 after castration (AT subgroup). In the BF subgroup, three proteins were significantly upregulated and associated with dihydrotestosterone: solute carrier family 5 member 5, tyrosine-protein kinase, and FRAT regulator of WNT signaling pathway 1. Additionally, the overexpression of polymeric immunoglobulin receptors in the BF subgroup hints at its potential as a novel protein linked to the BPH development process. Conversely, alpha-1-B glycoprotein (A1BG) displayed significant downregulation in the BF subgroup, suggesting A1BG’s potential as a predictive protein for canine BPH. Finasteride was associated with increased proteins in the AT subgroup, including apolipoprotein C-I, apolipoprotein E, apolipoprotein A-II, TAO kinase 1, DnaJ homolog subfamily C member 16, PH domain and leucine-rich repeat protein phosphatase 1, neuregulin 1, and pseudopodium enriched atypical kinase 1. In conclusion, this pilot study highlighted alterations in various serum proteins in canine BPH, reflecting different pathological changes occurring in this condition. These proteins could be a source of potential non-invasive biomarkers for diagnosing this disease.